Gadolinium-DTPA in spinal disease.
The use of paramagnetic contrast agents, in particular, gadolinium-DTPA, holds great promise for the MR evaluation of the spine. However, because of the lack of a previous model for intravenous contrast enhancement in the spine and because of some peculiarities of enhancement of spinal lesions, close attention must be paid to the appropriate uses of contrast in MR of the spine. Gadolinium-DTPA appears to be extremely useful in intradural extramedullary disease and intramedullary disease, but its use in extradural disease may best be restricted to certain specific clinical situations.
Sze
G
G
Department of Radiology, Cornell University Medical College, New York, New York.
D000328:Adult; D000368:Aged; D003287:Contrast Media; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D007403:Intervertebral Disc / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D004369:Pentetic Acid; D013118:Spinal Cord Diseases / Q000175:diagnosis*; D013120:Spinal Cord Neoplasms / Q000175:diagnosis; D013122:Spinal Diseases / Q000175:diagnosis*; D013125:Spinal Neoplasms / Q000175:diagnosis
D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D019786:Gadolinium DTPA